Vyndaqel (tafamidis) is now approved in the U.S. after study showed increased survivorship rate and reduced hospital time due to heart related problems.
what is vyndaqel
-
-
September 10, 2018
Understand why approval doesn’t necessarily mean availability and what you can do if a medicine is approved, but not available in your country.
-
November 17, 2017
We talk to Sera, our Medicines Sourcing Manager about why drug delays happen...